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A B S T R A C T
Background
Human milk banking has been available in many countries for the last three decades. The milk provided from milk banking is predominantly
term breast milk, but some milk banks provide preterm breast milk. There are a number of diFerences between donor term and donor
preterm human milk.
Objectives
To determine the eFect of banked donor preterm milk compared with banked donor term milk regarding growth and developmental
outcomes in very low birth weight infants (infants weighing less than 1500 grams).
Search methods
We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2018,
Issue 7), MEDLINE via PubMed (1966 to 23 October 2018), Embase (1980 to 23 October 2018), and CINAHL (1982 to 23 October 2018). We
also searched clinical trial databases, conference proceedings, and the reference lists of retrieved articles for randomised controlled trials
and quasi-randomised trials.
Selection criteria
Randomised and quasi-randomised trials comparing banked donor preterm milk with banked donor term milk regarding growth and
developmental outcomes in very low birth weight infants
Data collection and analysis
We planned to perform assessment of methodology regarding blinding of randomisation, intervention and outcome measurements as
well as completeness of follow-up. We planned to evaluate treatment eFect using a fixed-eFect model using relative risk (RR), relative risk
reduction, risk diFerence (RD) and number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for
an additional harmful outcome (NNTH) for categorical data; and using mean, standard deviation and weighted mean diFerence (WMD) for
continuous data. We planned to use the GRADE approach to assess the quality of evidence.
Main results
No studies met the inclusion criteria.
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Authors' conclusions
We found no evidence to support or refute the eFect of banked donor preterm milk compared to banked term milk regarding growth and
developmental outcomes in very low birth weight infants.
P L A I N   L A N G U A G E   S U M M A R Y
Banked preterm versus banked term human milk to promote growth and development in very low birth weight infants
Review question
When mother's own milk is not available or is insuFicient, does feeding banked donor preterm milk compared to banked donor term milk
result in improved growth and neurodevelopmental outcome in very low birthweight infants?
Background
Donor-expressed milk processed by human milk banks has been used to provide preterm infants with breast milk when there are
circumstances that preclude the use of mother's own milk. Preterm milk diFers significantly from term breast milk. The processes involved
in providing donor milk, including freezing, thawing and pasteurisation has adverse eFects on nutritional and non-nutritional aspects of
donor milk. Donor milk is expensive. We wished to determine whether the benefits of preterm donor milk were superior to term donor
milk either as a sole diet, or as a supplement to mother's own milk.
Study characteristics
We were unable to identify any studies that compared donor preterm milk with donor term milk to promote growth and development in
very low birth weight infants. Evidence is up to date as of October 2018.
Key results
We were unable to conclude that donor preterm milk was superior to term donor milk as there is no evidence to support or refute this
question. However the lack of studies identified in the original review and now updated in this review means that it is extremely unlikely
that any such study will be performed.
Quality of evidence
There were no studies to make an assessment of quality of evidence.
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B A C K G R O U N D
Description of the condition
Mother's own milk is the milk of choice when feeding the preterm
very low birth weight infant. Human milk provides a variety of
benefits compared to formula. In preterm infants, reported benefits
include faster gastric emptying (Cavell 1981; Ewer 1994), faster
attainment of full enteral feeding (Uraizee 1989; Lucas 1990),
enhanced stimulation of gastrointestinal motility and improved
intestinal growth and maturation (Sheard 1988; Groer 1996).
Breast milk is associated with a reduction in the incidence of
necrotising enterocolitis (NEC) and late-onset sepsis (Narayanan
1984; Schanler 1999). Preterm infants fed human milk appear
to have improved neurodevelopmental outcome compared with
infants fed formula milk (Anderson 1999). This association has
been supported in the extremely low birth weight (ELBW) infant
(Vohr 2006). Neonates fed breast milk tend to have improved visual
development with less retinopathy of prematurity (Hylander 1995).
However, there are circumstances when mother's breast milk may
not be available. These circumstances occur when mothers cannot
provide their own milk due to illness, inability to produce breast
milk or due to concerns regarding certain prescription medications.
Description of the intervention
Human milk banking has been available in many countries for
the last three decades and has played an important role in
neonatal care. There are a number of donor milk banks in North
America, United Kingdom, Europe and Australia. Human milk is
donated to the milk bank voluntarily. Donors are screened for HIV,
hepatitis B and C, human T-lymphotropic virus and syphilis (Gibbins
2013). There has been a significant growth in the number of milk
banks internationally. The screening, processing and shipping of
donor breast milk incur considerable costs. The cost per ounce
of expressed milk supplied to institutions varies from country to
country. In the USA the estimated cost is USD 3 per ounce; in the
UK it is GBP 3 per ounce, including processing and shipping costs
(Arnold 2002).
Donor-expressed milk has been used to provide preterm infants
with breast milk when circumstances otherwise preclude the use
of mother's own milk. Exclusive feeding with donor breast milk has
been shown to reduce the incidence of NEC when compared to
formula (McGuire 2003; Boyd 2006), but growth was slower. This
benefit was only seen when breast milk was the sole dietary source.
Some studies using donor-banked milk or formula as a supplement
to mother's own milk did not find any significant diFerences in
reduction of NEC (Lucas 1984; Schanler 2005). There appears to be
no evidence supporting enhanced long-term outcome in infants fed
donor milk (Modi 2006; Quigley 2018).
How the intervention might work
The milk provided from milk banking is predominantly term
breast milk (oMen produced later in lactation so it has a
diFerent nutrient content), although many breast milk banking
services now also batch and provide donated preterm breast
milk (Tully 2001; Wight 2001). There are a number of diFerences
between term and preterm human milk (Gidrewicz 2014). The
nutritional and non-nutritional components of human milk diFer
as gestational age advances (Boyce 2016). The relative constituents
of protein, fat and carbohydrate diFer (Gross 1980; Butte
1984), as do the non-nutritional components including variations
in digestive hormones, growth factors, immunological factors,
vitamins, minerals and trace elements (Schanler 1980; Saarela
2005). Gidrewicz highlighted a preterm milk protein content of
2.2 g/dL and a fat content of 2.6 g/dL compared to term milk
protein content of 1.8 g/dL and a fat content of 2.2 g/dL in the
first week of life (Gidrewicz 2014). Long chain polyunsaturated fatty
acids (LCPUFA) found in both term and preterm milk may diFer.
LCPUFA play an important role in optimal brain development and
retinal maturation (Genzel-Boroviczeny 1997). Donor breast milk
undergoes a number of diFerent processes including freezing and
pasteurisation. These processes alter the nutritional composition
of the milk and may aFect preterm donor milk in a diFerent way
to term donor milk. Pasteurisation aFects nutritional components
resulting in slightly slower growth of infants on donor breast
milk compared to raw unpasteurized human milk (Stein 1986).
Pasteurisation aFects immunological factors resulting in lower
levels of lactoferrin and IgG. It eliminates white blood cells
and bacteria. Despite pasteurisation IgA, bifid growth factor and
lysozyme remain intact (Ford 1977). Holder pasteurisation (62.5
°C for 30 minutes) seems to be superior to heat treatment at 56
°C for 30 minutes in terms of cytomegalovirus elimination (Evans
1978). Freezing will eliminate most viruses and does not appear
to influence nutritional quality of the milk (Wight 2001). Freezing
does reduce the concentration of lysozyme by up to 20%, and
also destroys all white blood cells. Microwaving aFects the milk
in the same way as described with pasteurisation (Quan 1992).
Other newer methods of pasteurisation may have diFerent eFects
on donor milk composition.
Why it is important to do this review
The inherent nutritional and non-nutritional components of
preterm and term donor milk diFer (Gidrewicz 2014). The eFects
of freezing and pasteurisation alter the composition of donor milk,
and may alter preterm and term donor milk diFerently. Therefore,
the eFect of banked donor preterm milk compared to donor term
milk in feeding the very low birthweight infant warrants further
investigation.
O B J E C T I V E S
To determine the eFect of banked donor preterm milk compared
with banked donor term milk regarding growth and developmental
outcomes in very low birth weight infants (infants weighing less
than 1500 grams).
The following comparisons were planned.
1. Any banked donor preterm milk (with or without fortification)
versus any banked donor term milk (with or without
fortification)
2. Banked donor preterm milk (with or without fortification) versus
banked donor term milk (with or without fortification) where
both were used as sole enteral diet
3. Any banked donor preterm milk (with or without fortification)
versus any banked donor term milk (with or without
fortification) in the extremely low birth weight infant
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M E T H O D S
Criteria for considering studies for this review
Types of studies
Trials using randomisation or quasi-randomisation of patients
were eligible for inclusion. Published or unpublished studies were
eligible for inclusion. We would have included unpublished studies
or studies published only as abstracts if assessment of study quality
was possible and if other criteria for inclusion were fulfilled.
Types of participants
Very low birth weight infants (infants weighing less than 1500
grams) fed donor banked human milk. Infants receiving partial
enteral feeding (formula or mother's own milk) at study entry were
eligible.
Types of interventions
Use of banked donor preterm milk versus banked donor term milk
with or without fortification fed either as a sole enteral diet or as a
supplement to mother's own milk.
Types of outcome measures
Primary outcomes
1. Short-term growth parameters: time to regain birth weight
(days of life), weight gain (grams/day), length gain (centimetres/
week), head growth (centimetres/week) at discharge;
2. Longer-term growth parameters (following discharge from
hospital): weight gain (grams/week), length gain (centimetres/
week), head growth (centimetres/week) at four months' follow-
up;
3. Neurodevelopmental outcomes at term corrected age and at 18
to 24 months using validated assessment tools.
Secondary outcomes
1. Incidence of necrotising enterocolitis (defined as Bell's Stage 2
or greater);
2. Incidence of late onset sepsis;
3. Duration of total parenteral nutrition use (days);
4. Time to full enteral feeds (days);
5. Feeding intolerance defined as abdominal distension with large
gastric residuals (> 50% of previous feed).
Search methods for identification of studies
We used the standard search strategy of Cochrane Neonatal.
Electronic searches
We conducted a comprehensive search including the Cochrane
Central Register of Controlled Trials (CENTRAL 2018, Issue 7 in
the Cochrane Library), MEDLINE via PubMed (1966 to 23 October
2018), Embase (1980 to 23 October 2018) and CINAHL (1982 to 23
October 2018) using the search terms detailed in Appendix 1. We did
not apply language restrictions. This search was an update of the
searches run for the review first published in 2010 (see Appendix 2
for previous search details) (Dempsey 2010).
We searched clinical trial registries for ongoing or recently
completed trials (clinicaltrials.gov; the World Health Organization’s
International Trials Registry and Platform www.whoint/ictrp/
search/en; and the ISRCTN Registry) on 23 October 2018.
Searching other resources
Other searches included reference lists of all selected articles as
well as review articles. We also searched unpublished, in press
and in progress trials and abstracts from neonatal and paediatric
meetings. This included the proceedings of the Pediatric Academic
Society meetings (PAS electronic version from 2000 to 2018) and the
European Society for Paediatric Research meetings (from 2000 to
2018). Trials reported only as abstracts were considered eligible if
there was suFicient information available from the report or from
contact with the authors.
Data collection and analysis
We used the standard methods of Cochrane Neonatal.
Selection of studies
We applied machine learning using the Cochrane Classifier
tool in the Cochrane Register of Studies (CRS) to assess, then
remove, reports with the least (0% to 2%) probability of being
randomised controlled trials and with the least (0% to 2%)
probability of having infants in the population. Each review author
independently searched for trials and selected studies for inclusion
with comparison and resolution of any diFerences. We illustrate our
findings in a flowchart (Figure 1).
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Figure 1.   Study flow diagram: review update
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Figure 1.   (Continued)
 
Data extraction and management
If eligible trials had been identified, each review author planned to
independently extract the data and compare results. We planned
to use a data collection form to aid extraction of information
on design, methodology, participants, intervention outcomes and
treatment eFects from included studies. We planned to resolve any
disagreements through discussion.
Assessment of risk of bias in included studies
The two review authors planned to independently assess the risk of
bias (low, high, or unclear) of all included trials using the Cochrane
‘Risk of bias’ tool, as described in Higgins 2017, for the following
domains.
• Sequence generation (selection bias)
• Allocation concealment (selection bias)
• Blinding of participants and personnel (performance bias)
• Blinding of outcome assessment (detection bias)
• Incomplete outcome data (attrition bias)
• Selective reporting (reporting bias)
• Any other bias
We planned to resolve any disagreements by discussion or by
inviting a third assessor to arbitrate. See Appendix 3 for a more
detailed description of risk of bias for each domain.
Measures of treatment eAect
We planned to evaluate categorical data by calculating the relative
risk (RR), relative risk reduction, risk diFerence (RD) and number
needed to treat for an additional beneficial outcome (NNTB) or the
number needed to treat for an additional harmful outcome (NNTH).
We intended to obtain mean and standard deviation for continuous
data and perform analysis using the weighted mean diFerence
(WMD). For each measure of eFect, we planned to calculate the 95%
confidence interval.
Unit of analysis issues
Our planned unit of analysis was the participating infant in
individually randomised controlled trials.
Dealing with missing data
Where data were missing, we planned to deal with this by firstly
contacting the relevant author. If we assumed that the data were
missing at random, we planned to analyse the data without
imputing any missing data.
Assessment of heterogeneity
We planned to examine heterogeneity between trials by inspecting
the forest plots and quantifying the impact of heterogeneity using
the I2 statistic. If we detected statistical heterogeneity (I2 > 50%) we
planned to explore the possible causes (for example, diFerences
in study quality, participants, intervention regimens, or outcome
assessments) using post hoc subgroup analyses.
Assessment of reporting biases
We planned to examine a funnel plot for asymmetry if there were
more than 10 included trials.
Data synthesis
If we had identified multiple studies and judged that meta-analysis
was appropriate, we would have performed the analysis using
Cochrane's Review Manager 5 soMware (Review Manager 2014). For
estimates of typical relative risk and risk diFerence, we planned
to use the Mantel-Haenszel method. For measured quantities,
we planned to use the inverse variance method. We intended to
conduct all meta-analyses using the fixed-eFect model.
Quality of evidence
We planned to use the GRADE approach, as outlined in the
GRADE Handbook (Schünemann 2013), to assess the quality of
evidence for the following (clinically relevant) outcomes: growth,
neurodevelopmental outcome, NEC and sepsis.
Review authors planned to independently assess the quality of the
evidence for each of the outcomes above. We planned to consider
evidence from randomised controlled trials as high quality but to
downgrade the evidence one level for serious (or two levels for very
serious) limitations based upon the following: design (risk of bias),
consistency across studies, directness of the evidence, precision of
estimates and presence of publication bias. We planned to use the
GRADEpro GDT Guideline Development Tool to create a ‘Summary
of findings’ table to report the quality of the evidence(GRADEpro
GDT).
The GRADE approach results in an assessment of the quality of a
body of evidence in one of the following four grades.
1. High: we are very confident that the true eFect lies close to that
of the estimate of the eFect.
2. Moderate: we are moderately confident in the eFect estimate:
the true eFect is likely to be close to the estimate of the eFect,
but there is a possibility that it is substantially diFerent.
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3. Low: our confidence in the eFect estimate is limited: the true
eFect may be substantially diFerent from the estimate of the
eFect.
4. Very low: we have very little confidence in the eFect estimate:
the true eFect is likely to be substantially diFerent from the
estimate of eFect.
Subgroup analysis and investigation of heterogeneity
The primary objective was to compare any banked preterm donor
milk (with or without fortification) to any banked term donor milk
(with or without fortification).
Subgroup comparisons of preterm donor milk with fortification
to banked term donor milk with fortification and preterm donor
milk without fortification to banked term donor milk without
fortification were planned as following for each comparison.
Any banked donor preterm milk (with or without fortification)
versus any banked donor term milk (with or without
fortification)
The following subgroups were planned.
1. Banked preterm milk with fortification (using multi-component
breast milk fortifier) versus banked term milk with fortification
(using multi-component breast milk fortifier).
2. Banked preterm milk without fortification versus banked term
milk without fortification.
Banked donor preterm milk (with or without fortification)
versus banked donor term milk (with or without fortification)
where both were used as sole enteral diet
The following subgroups were planned.
1. Banked donor preterm milk with fortification versus any banked
donor term milk with fortification where both were used as sole
enteral diet.
2. Any banked donor preterm milk without fortification versus any
banked donor term milk without fortification where both were
used as sole enteral diet.
Any banked donor preterm milk (with or without fortification)
versus any banked donor term milk (with or without
fortification) in the extremely low birth weight infant
The following subgroups were planned.
1. Any banked donor preterm milk with fortification versus any
banked donor term milk with fortification in the extremely low
birth weight infant.
2. Any banked donor preterm milk without fortification versus any
banked donor term milk without fortification in the extremely
low birth weight infant.
Sensitivity analysis
There was no planned sensitivity analysis.
R E S U L T S
Description of studies
Please see Figure 1 outlining the results of the search.
Results of the search
Please see Figure 1 outlining the results of the search.
Included studies
There were no new studies identified for inclusion in this review.
Excluded studies
See Characteristics of excluded studies table. A number of
randomised clinical trials studies compared donor breast milk
with formula (Gross 1983; Tyson 1983; Lucas 1990; Schanler 2005;
Cristafolo 2013; Corpelejin 2016; O'Connor 2016); and some of
these were the subject of a series of systematic reviews (McGuire
2003; Quigley 2007; Quigley 2014; Quigley 2018). None, however,
compared donor preterm milk with donor term milk. One study
compared pooled pasteurised breast milk with untreated mother's
own milk but did not compare donor preterm milk with donor
term milk (Stein 1986). Another study compared pooled pasteurised
breast milk with untreated mother's own milk but again did not
compare donor preterm versus term milk; it was also a before-aMer
study (Montjaux-Régis 2011).
Risk of bias in included studies
No studies met the inclusion criteria.
Allocation
No studies met the inclusion criteria.
Blinding
No studies met the inclusion criteria.
Incomplete outcome data
No studies met the inclusion criteria.
Selective reporting
No studies met the inclusion criteria.
Other potential sources of bias
No studies met the inclusion criteria.
EAects of interventions
No studies met the inclusion criteria.
D I S C U S S I O N
We found no randomised controlled trials comparing banked
preterm breast milk with banked term breast milk in the very
low birth weight infant; therefore, this systematic review did
not establish whether preterm donor milk conferred any health
benefits compared to term donor milk fed solely, or as part of, the
overall enteral diet of the very low birth weight infant. There have
been a number of more recent studies comparing donor milk to
formula for feeding the preterm infant and these have been the
subject of a recent systematic review (Quigley 2018). This review
highlighted reduction in NEC, but lower rates of weight gain, linear
growth, and head growth in the donor milk group. There was
no diFerence in all-cause mortality or long-term outcome in this
systematic review.
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Each of these studies used pooled pasteurised breast milk, a
combination of both preterm and (predominantly) term donor milk
and so it is not possible to determine whether preterm donor
milk had a greater influence on outcome compared with term
donor milk. It is biologically plausible that preterm donor milk
may confer additional benefits to the preterm infant compared
to term donor milk because the nutritional components diFer
significantly. The non-nutritional components also diFer, including
variations in digestive hormones, growth factors, immunological
factors, vitamins, minerals and trace elements, all of which may
contribute to improved well-being in the preterm infant.
The lack of included studies since the previous review and the
lack of any current registered clinical trials highlight that it is
unlikely that there would be any future randomised controlled
trials comparing preterm donor milk with term donor milk, where
each is the sole agent used. The most obvious reason is because of a
very limited supply of donated preterm milk to milk banks. The vast
majority of donors are from mothers who have delivered full-term
and have a large milk supply. Thus the limited supply of preterm
donor milk, either because of limited donated volumes or limited
numbers of breast milk banks that supply pooled preterm donor
breast milk, means performing such studies would be diFicult.
Future randomised controlled trials could potentially be performed
comparing preterm with term banked breast milk as an adjunct to
mother's own milk or as an adjunct to formula feeding in the very
low birth weight infant. However the same limitations would apply
as highlighted above, which make it extremely unlikely that any
such trial would be performed. It is more likely that future studies
would focus on optimisation of the pooled undiFerentiated donor
milk content in the form of individualized fortification regimes.
Summary of main results
No included studies
Overall completeness and applicability of evidence
No included studies
Quality of the evidence
No included studies
Potential biases in the review process
No potential biases identified
Agreements and disagreements with other studies or
reviews
This is an update of the previous review. This review again identified
no new studies.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
In this most recent update, again we found no randomised
controlled trials that compared banked preterm milk versus
banked term milk to promote growth and development in very low
birth weight infants.
Implications for research
Although it is biologically plausible that banked preterm milk may
be more suitable than banked term milk in feeding the preterm
infant, it is unlikely that there would be any future randomised
controlled trials comparing either milk source as a sole agent or
an adjunct to mother's own milk or formula feeding. It is more
likely that future studies would focus on optimisation of pooled
undiFerentiated donor milk in very low birth weight infants via
diFerent milk fortification methods.
A C K N O W L E D G E M E N T S
The Methods section of this review is based on a standard template
used by Cochrane Neonatal. We would like to sincerely thank Ms
Colleen Ovelman for her support in performing this review.
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milk.
Stein 1986 This study compared pooled pasteurised breast milk with untreated mother's own milk.
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A P P E N D I C E S
Appendix 1. Search strategy
PubMed:
(((Milk, Human[MeSH] OR breastmilk[TW] OR ((human[TW] OR breast*[TW] OR mother*[TW] OR maternal[TW] OR expressed[TW]) AND
milk*[TW]) OR milk ejection[MeSH] OR Breast Milk Expression[MeSH])) AND (Milk Banks[MeSH] OR bank*[TW] OR milkbank*[TW] OR
donor*[TW] OR (donor*[TW] AND milk*[TW]) OR (bank*[TW] AND milk*[TW])) AND ((infant, newborn[MeSH] OR newborn*[TIAB] OR "new
born"[TIAB] OR "new borns"[TIAB] OR "newly born"[TIAB] OR baby*[TIAB] OR babies[TIAB] OR premature[TIAB] OR prematurity[TIAB] OR
preterm[TIAB] OR "pre term"[TIAB] OR "low birth weight"[TIAB] OR "low birthweight"[TIAB] OR VLBW[TIAB] OR LBW[TIAB] OR infant[TIAB]
OR infants[TIAB] OR infantile[TIAB] OR infancy[TIAB] OR neonat*[TIAB]) AND (randomized controlled trial[pt] OR controlled clinical trial[pt]
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OR randomized[tiab] OR placebo[tiab] OR drug therapy[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (animals[mh] NOT
humans[mh]))) Filters: Publication date from 2010/01/01
Embase:
1. exp breast milk/
2. exp milk ejection/
3. exp breast milk expression/
4. ((human or breast* or mother* or expressed or maternal) and milk*).mp.
5. breastmilk.mp.
6. 1 or 2 or 3 or 4 or 5
7. exp milk bank/
8. (milkbank* or bank* or donor*).mp.
9. ((bank* and milk*) or (donor* and milk*)).mp.
10. 7 or 8 or 9
11. exp prematurity/
12. exp infant/
13. (newborn* or new born or new borns or newly born or baby* or babies or premature or prematurity or preterm or pre term or low birth
weight or low birthweight or VLBW or LBW or infant or infants or infantile or infancy or neonat*).ti,ab.
14. 11 or 12 or 13
15. (human not animal).mp.
16. (randomized controlled trial or controlled clinical trial or randomized or placebo or clinical trials as topic or randomly or trial or clinical
trial).mp.
17. 14 and 15 and 16
18. 6 and 10 and 17
19. limit 18 to yr="2010 -Current"
CINAHL:
(breastmilk OR ((human OR breast* OR mother* OR maternal OR expressed OR ejection) AND milk*)) AND (bank* OR milkbank* OR donor*
OR (donor* AND milk*) OR (bank* AND milk*)) AND (infant or infants or infantile or infancy or newborn* or "new born" or "new borns" or
"newly born" or neonat* or baby* or babies or premature or prematures or prematurity or preterm or preterms or "pre term" or premies
or "low birth weight" or "low birthweight" or VLBW or LBW) AND (randomized controlled trial OR controlled clinical trial OR randomized
OR placebo OR clinical trials as topic OR randomly OR trial OR PT clinical trial)
Limited to 2010-18
CENTRAL:
1MESH DESCRIPTOR Milk, Human EXPLODE ALL AND CENTRAL:TARGET
2MESH DESCRIPTOR Milk Ejection EXPLODE ALL AND CENTRAL:TARGET
3MESH DESCRIPTOR Breast Milk Expression EXPLODE ALL AND CENTRAL:TARGET
4breastmilk OR ((human OR breast* OR mother* OR maternal OR expressed) AND milk*) AND CENTRAL:TARGET
5#1 OR #2 OR #3 OR #4 AND CENTRAL:TARGET
6MESH DESCRIPTOR Milk Banks EXPLODE ALL AND CENTRAL:TARGET
7bank* OR milkbank* OR donor* OR (donor* AND milk*) OR (bank* AND milk*) AND CENTRAL:TARGET
8#7 OR #6 AND CENTRAL:TARGET
9infant or infants or infantile or infancy or newborn* or "new born" or "new borns" or "newly born" or neonat* or baby* or babies or
premature or prematures or prematurity or preterm or preterms or "pre term" or premies or "low birth weight" or "low birthweight" or
VLBW or LBW or ELBW or NICU AND CENTRAL:TARGET
10#5 AND #8 AND #9 AND CENTRAL:TARGET




Search terms: ((banked OR donor*) AND (milk OR breastmilk)) OR milkbank* | Child | First posted from 01/01/2010 to 07/10/2020
ISRCTN.com:
Search terms: (infant OR neonate) AND (((banked OR donor*) AND (breastmilk OR milk)) OR milkbank*)
WHO:
Search terms: (infant OR neonate) AND (((banked OR donor*) AND (breastmilk OR milk)) OR milkbank*) - limited to “Clinical trials in
children”
January 2010 to current
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Appendix 2. Previous search details
For the review published in 2010, electronic searches included a search of the Cochrane Neonatal Group specialized register and the
Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, January 2010). We identified relevant studies by searching
the following: (1) computerised bibliographic databases: MEDLINE (1966 to February 2010), EMBASE (1988 to February 2010) and Web of
Science (1975 to February 2010); (2) the Oxford Database of Perinatal Trials. The electronic search included the following keywords "donor
expressed milk", "banked expressed milk" and MeSH search terms "Infant, Newborn" AND "Milk, Human" AND "Milk Banks". We limited
trials to clinical trials where 'limits' option was available. We applied no language restrictions.
Appendix 3. 'Risk of bias' tool
We planned to use the standard methods of Cochrane and Cochrane Neonatal to assess the methodological quality of the trials. For each
trial, we planned to seek information regarding the method of randomisation, blinding and reporting of all outcomes of all the infants
enrolled in the trial. We planned to assess each criterion as being at a low, high, or unclear risk of bias. Two review authors planned to
separately assess each study. We planned to resolve any disagreement by discussion. We planned to add this information to the table
'Characteristics of included studies'. We planned to evaluate the following issues and enter the findings into the 'Risk of bias' table.
1. Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?
For each included study, we planned to categorize the method used to generate the allocation sequence as:
• low risk (any truly random process e.g. random number table; computer random number generator);
• high risk (any non-random process e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk.
2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?
For each included study, we planned to categorize the method used to conceal the allocation sequence as:
• low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or
• unclear risk
3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention
adequately prevented during the study?
For each included study, we planned to categorize the methods used to blind study participants and personnel from knowledge of which
intervention a participant received. Blinding was planned to be assessed separately for diFerent outcomes or class of outcomes. We
planned to categorize the methods as:
• low risk, high risk or unclear risk for participants; and
• low risk, high risk or unclear risk for personnel.
4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately
prevented at the time of outcome assessment?
For each included study, we planned to categorize the methods used to blind outcome assessment. Blinding was planned to be assessed
separately for diFerent outcomes or class of outcomes. We planned to categorize the methods as:
• low risk for outcome assessors;
• high risk for outcome assessors; or
• unclear risk for outcome assessors.
5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were incomplete
outcome data adequately addressed?
For each included study and for each outcome, we planned to describe the completeness of data including attrition and exclusions from the
analysis. We planned to note whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared
with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across
groups or were related to outcomes. Where suFicient information was reported or supplied by the trial authors, we planned to re-include
missing data in the analyses. We planned to categorize the methods as:
• low risk (< 20% missing data);
• high risk (≥ 20% missing data); or
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• unclear risk.
6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?
For each included study, we planned to describe how we investigated the possibility of selective outcome reporting bias and what we
found. For studies in which study protocols were published in advance, we planned to compare prespecified outcomes versus outcomes
eventually reported in the published results. If the study protocol was not published in advance, we planned to contact study authors to
gain access to the study protocol. We planned to assess the methods as:
• low risk (where it is clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review have been
reported);
• high risk (where not all the study's prespecified outcomes have been reported; one or more reported primary outcomes were not
prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported); or
• unclear risk.
7. Other sources of bias. Was the study apparently free of other problems that could put it at a high risk of bias?
For each included study, we planned to describe any important concerns we had about other possible sources of bias (for example, whether
there was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data-dependent




If needed, we planned to explore the impact of the level of bias through undertaking sensitivity analyses.
W H A T ' S   N E W
 
Date Event Description
8 July 2020 Amended Typo in Declarations of interest section corrected
 
H I S T O R Y
Protocol first published: Issue 1, 2009
Review first published: Issue 6, 2010
 
Date Event Description
4 June 2019 New citation required but conclusions
have not changed
No new studies were found.
23 April 2019 New search has been performed Updated review of Dempsey 2010.
 
C O N T R I B U T I O N S   O F   A U T H O R S
Dr. Dempsey conceived and designed the review.
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We added the methodology and plan for 'Summary of findings' tables and GRADE recommendations, which were not included in the
original protocol. We updated the search methods for the 2019 publication.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Infant, Premature  [growth & development];  *Infant, Very Low Birth Weight;  *Milk Banks;  Milk, Human;  Randomized Controlled Trials
as Topic
MeSH check words
Humans; Infant; Infant, Newborn
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